Group One Trading
CTXR icon

Group One Trading’s Citius Pharmaceuticals CTXR Stock Holding History

Group One Trading’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,552
Closed -$57K – 7392
2024
Q3 		$57K Buy
+4,552
New +$76.6K ﹤0.01% 4565
2024
Q2 		– Sell
-8
Closed -$179 – 6844
2024
Q1 		$179 Sell
8
-3,544
-100% -$64.7K ﹤0.01% 6818
2023
Q4 		$67.2K Sell
3,552
-10,080
-74% -$191K ﹤0.01% 4818
2023
Q3 		$233K Sell
13,632
-228
-2% -$5.42K ﹤0.01% 3668
2023
Q2 		$416K Buy
13,860
+8,368
+152% +$275K ﹤0.01% 3201
2023
Q1 		$161K Sell
5,492
-4,808
-47% -$139K ﹤0.01% 3870
2022
Q4 		$203K Sell
10,300
-7,568
-42% -$206K ﹤0.01% 3850
2022
Q3 		$541K Buy
+17,868
New +$491K ﹤0.01% 3151

Other funds holding CTXR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return

Group One Trading's CTXR Position: Q3 2025 in Review

Group One Trading sold out of Citius Pharmaceuticals (CTXR) in Q3 2025, closing a stake of 649 shares — an estimated $1.03K sold.

Group One Trading first reported a position in CTXR in Q3 2022 and held it in 11 quarters. The position peaked at $57.2K in Q1 2023. 34 funds tracked by Wall St. Rank hold CTXR as of Q3 2025.

  • Group One Trading reported no remaining Citius Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 649 Citius Pharmaceuticals shares in Q3 2025, an estimated $1.03K.
  • Group One Trading first reported a position in Citius Pharmaceuticals in Q3 2022 and held it in 11 quarters.
  • Group One Trading's Citius Pharmaceuticals position peaked at $57.2K in Q1 2023.
  • 34 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.